MNPR Reports Positive Phase 2 ALXN1840 Data, Shows -0.37mg Daily Copper Balance Change, 50% Increase in Fecal Copper Output-to-Intake Ratio
Monopar Therapeutics Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $64.40
+18% in 7d after detection
Post-detection moves
1h
—
1d
+18%
3d
+14%
7d
+18%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS